Oculis Holding AG

Approval AI-extracted

OCS-01

diabetic macular edema

Resolved

98days ago

Approval decision · ~ Mar 31, 2026 estimated

What's at stake A final FDA approval decision on OCS-01 for diabetic macular edema is expected ~ Mar 31, 2026.

Primary source · SEC 6-K verified 12h ago

“a subsequent New Drug Application (NDA) submission to the U.S. Food and Drug Administration (FDA) planned for Q4 2026 following a positive readout.”

4 sources on file.

Link copied ✓